This Week in Psychedelics - 12.4.20

ThisWeekinPsychedelics.png

Cannabis

  • House Approves Federal Marijuana Legalization Bill In Historic Vote (Marijuana Moment)

  • U.N. Reclassifies Cannabis as a Less Dangerous Drug (The New York Times)

  • MORE Act Approved by House Rules Committee (NORML)

  • These States Could Have Marijuana Legalization On Their 2022 Ballots (Marijuana Moment)

  • Arizona: Prop. 207 Legalization Measure Officially Takes Effect (NORML)

  • CBD Doesn’t Impair Driving, Landmark Study Finds, While THC’s Effects Fade In Hours (Marijuana Moment)

  • DEA Asks Federal Court To Dismiss Marijuana Rescheduling Lawsuit—Again (Marijuana Moment)

  • Lawsuit Filed Against the DEA and Attorney General to Compel Issuance of Licenses to Manufacture Marijuana for Clinical Trials and Potential FDA Approval (MAPS)

  • The Future Of The Cannabis Industry After The Pandemic (Forbes)

  • “No Evidence” that Adult-Use Marijuana Laws Influence Cannabis Use by Teens (NORML)

  • What History Teaches Us About Shaping South Africa's New Cannabis Laws (TalkingDrugs)

  • How pagans used cannabis at Christmastime (Leafly)

LSD

  • ‘We have a drug problem’: Camp Lejeune starts random LSD testing (Stars and Stripes)

  • Silo Pharma Announces Plans for a Phase 2B Investigator Lead Study Using Psychedelics Psilocybin and Lysergic Acid Diethylamide (“LSD”) to Treat Parkinson’s Disease (Psilocybin Alpha)

  • I'm an 'LSD Specialist' Who Sells Acid to Oxford University Students (VICE)

Magic Mushrooms

  • Oregon Governor Takes First Step To Regulate Psilocybin Mushroom Therapy By Forming New Board (Marijuana Moment)

  • Understanding The Psilocybin Supply Chain: Every Production Method Explained (Yahoo! Finance)

MDMA

  • Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial (Psilocybin Alpha)

DMT

  • Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021 (Psilocybin Alpha)

Ayahuasca

  • Coronavirus and Evolving Ceremonial Practice Among Ayahuasca Practitioners in the US (Chacruna)

  • Ayahuasca, Healing and Cognitive Justice (Chacruna)

5-MeO-DMT

  • Mike Tyson credits toad venom for his return to boxing ring (New York Post)

Salvia Divinorum

Novel Psychoactive Substances

  • CaaMTech Researchers Synthesize and Structurally Characterize Deprocin Hydrochloride (Psilocybin Alpha)

  • Tackling the Global Issue of New Psychoactive Substances (News-Medical.net)

Ketamine

Miscellaneous

  • Where Will Psychedelics and Other Drugs Be Decriminalized Next? (DoubleBlind)

  • 'Sistine Chapel of the ancients' rock art discovered in remote Amazon forest (The Guardian)

  • New Study Identifies Link Between Personality Traits And Psychedelic Experiences (IFLScience)

  • Leaked FBI Report: Drug Sellers Practice Harm Reduction (Filter)

  • What will 'psychedelic therapy' look like when it's legalized? (Big Think)

  • How Do American Psychiatrists View Psychedelics? (Psychedelic Support)

  • How Are Psychedelics Companies Generating Revenue Before Legalization? (Microdose)

  • Psychedelics, Masculinity, and Mental Health (Sam Woolfe)

  • “Please Write Up Your Work!”: Laura Archera Huxley as a Psychedelic Pioneer (Chacruna)

  • A Sub-Perceptual Promise: Can Microdosing Solve Mainstream Problems? (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.